Medications for Myasthenia Gravis Generalized

7 results

  • bkemv - eculizumab - aeeb injection, solution, concentrate

    (Eculizumab-Aeeb)
    Amgen Inc
    BKEMV is a complement inhibitor indicated for paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis, atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy, and generalized myasthenia gravis (gMG) in AChR antibody-positive adults. Not indicated for STEC-HUS.
    Medication Details
    Drug Interactions

  • rystiggo - rozanolixizumab injection, solution

    (Rozanolixizumab)
    Ucb, Inc.
    RYSTIGGO treats generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
    Medication Details
    Drug Interactions

  • soliris - eculizumab injection, solution, concentrate

    (Eculizumab)
    Alexion Pharmaceuticals Inc.
    Soliris treats paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG) in AChR antibody-positive patients aged 6 and older, and neuromyelitis optica spectrum disorder (NMOSD) in AQP4 antibody-positive adults. Not indicated for STEC-HUS.
    Medication Details
    Drug Interactions

  • ultomiris - ravulizumab solution, concentrate

    (Ravulizumab)
    Alexion Pharmaceuticals Inc.
    Ultomiris treats PNH and aHUS (including complement-mediated TMA) in adults and pediatric patients one month and older. Also indicated for AChR antibody-positive generalized myasthenia gravis and AQP4 antibody-positive neuromyelitis optica spectrum disorder in adults. Not for STEC-HUS.
    Medication Details
    Drug Interactions

  • uplizna - inebilizumab injection

    (Inebilizumab)
    Horizon Therapeutics Usa, Inc.
    Uplizna treats NMOSD in AQP4 antibody-positive adults, IgG4-related disease in adults, and generalized myasthenia gravis in adults who are AChR or MuSK antibody positive.
    Medication Details
    Drug Interactions

  • vyvgart hytrulo - efgartigimod alfa and hyaluronidase

    (Efgartigimod Alfa And Hyaluronidase (Human Recombinant))
    Argenx Us
    Vyvgart Hytrulo treats adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive, and adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Medication Details
    Drug Interactions